Efficiency of hyaloglide ® in the prevention of the recurrence of adhesions after tenolysis of flexor tendons in zone II

A randomized, controlled, multicentre clinical trial

M. Riccio, B. Battiston, G. Pajardi, M. Corradi, U. Passaretti, A. Atzei, M. Altissimi, L. Vaienti, F. Catalano, M. Del Bene, P. Fasolo, M. Ceruso, R. Luchetti, A. Landi

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Hyaloglide® is a hyaluronan-based gel based on a novel auto-crosslinked technology designed to reduce postsurgical adhesions. Its efficacy was assessed in a multicentred randomized controlled trial comparing the results of flexor tenolysis in zone 2 following failed flexor tendon repairs. In the control group a standard release was performed. In the treated group, Hyaloglide® was applied into the flexor sheath and around the site of tenolysis. Forty-five patients, 19 controls and 26 treated with Hyaloglide®, were enrolled in 13 centres. All the patients were evaluated at 30, 60, 90 and 180 days after surgery by testing Total Active Motion, Quick-DASH questionnaire and number of working days lost after surgery. Patients in the Hyaloglide® group had a statistically better recovery of finger motion at all time intervals and returned earlier to work and daily activities. The use of Hyaloglide® did not appear to increase the complication rate.

Original languageEnglish
Pages (from-to)130-138
Number of pages9
JournalJournal of Hand Surgery: European Volume
Volume35
Issue number2
DOIs
Publication statusPublished - Feb 2010

Fingerprint

Tendons
Multicenter Studies
Randomized Controlled Trials
Recurrence
Hyaluronic Acid
Ambulatory Surgical Procedures
Fingers
Gels
hyaloglide
Technology
Control Groups

ASJC Scopus subject areas

  • Surgery
  • Medicine(all)

Cite this

Efficiency of hyaloglide ® in the prevention of the recurrence of adhesions after tenolysis of flexor tendons in zone II : A randomized, controlled, multicentre clinical trial. / Riccio, M.; Battiston, B.; Pajardi, G.; Corradi, M.; Passaretti, U.; Atzei, A.; Altissimi, M.; Vaienti, L.; Catalano, F.; Del Bene, M.; Fasolo, P.; Ceruso, M.; Luchetti, R.; Landi, A.

In: Journal of Hand Surgery: European Volume, Vol. 35, No. 2, 02.2010, p. 130-138.

Research output: Contribution to journalArticle

Riccio, M, Battiston, B, Pajardi, G, Corradi, M, Passaretti, U, Atzei, A, Altissimi, M, Vaienti, L, Catalano, F, Del Bene, M, Fasolo, P, Ceruso, M, Luchetti, R & Landi, A 2010, 'Efficiency of hyaloglide ® in the prevention of the recurrence of adhesions after tenolysis of flexor tendons in zone II: A randomized, controlled, multicentre clinical trial', Journal of Hand Surgery: European Volume, vol. 35, no. 2, pp. 130-138. https://doi.org/10.1177/1753193409342044
Riccio, M. ; Battiston, B. ; Pajardi, G. ; Corradi, M. ; Passaretti, U. ; Atzei, A. ; Altissimi, M. ; Vaienti, L. ; Catalano, F. ; Del Bene, M. ; Fasolo, P. ; Ceruso, M. ; Luchetti, R. ; Landi, A. / Efficiency of hyaloglide ® in the prevention of the recurrence of adhesions after tenolysis of flexor tendons in zone II : A randomized, controlled, multicentre clinical trial. In: Journal of Hand Surgery: European Volume. 2010 ; Vol. 35, No. 2. pp. 130-138.
@article{eefc670da4bd421e90d5b9a0d683ecf4,
title = "Efficiency of hyaloglide {\circledR} in the prevention of the recurrence of adhesions after tenolysis of flexor tendons in zone II: A randomized, controlled, multicentre clinical trial",
abstract = "Hyaloglide{\circledR} is a hyaluronan-based gel based on a novel auto-crosslinked technology designed to reduce postsurgical adhesions. Its efficacy was assessed in a multicentred randomized controlled trial comparing the results of flexor tenolysis in zone 2 following failed flexor tendon repairs. In the control group a standard release was performed. In the treated group, Hyaloglide{\circledR} was applied into the flexor sheath and around the site of tenolysis. Forty-five patients, 19 controls and 26 treated with Hyaloglide{\circledR}, were enrolled in 13 centres. All the patients were evaluated at 30, 60, 90 and 180 days after surgery by testing Total Active Motion, Quick-DASH questionnaire and number of working days lost after surgery. Patients in the Hyaloglide{\circledR} group had a statistically better recovery of finger motion at all time intervals and returned earlier to work and daily activities. The use of Hyaloglide{\circledR} did not appear to increase the complication rate.",
author = "M. Riccio and B. Battiston and G. Pajardi and M. Corradi and U. Passaretti and A. Atzei and M. Altissimi and L. Vaienti and F. Catalano and {Del Bene}, M. and P. Fasolo and M. Ceruso and R. Luchetti and A. Landi",
year = "2010",
month = "2",
doi = "10.1177/1753193409342044",
language = "English",
volume = "35",
pages = "130--138",
journal = "Hand",
issn = "1753-1934",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Efficiency of hyaloglide ® in the prevention of the recurrence of adhesions after tenolysis of flexor tendons in zone II

T2 - A randomized, controlled, multicentre clinical trial

AU - Riccio, M.

AU - Battiston, B.

AU - Pajardi, G.

AU - Corradi, M.

AU - Passaretti, U.

AU - Atzei, A.

AU - Altissimi, M.

AU - Vaienti, L.

AU - Catalano, F.

AU - Del Bene, M.

AU - Fasolo, P.

AU - Ceruso, M.

AU - Luchetti, R.

AU - Landi, A.

PY - 2010/2

Y1 - 2010/2

N2 - Hyaloglide® is a hyaluronan-based gel based on a novel auto-crosslinked technology designed to reduce postsurgical adhesions. Its efficacy was assessed in a multicentred randomized controlled trial comparing the results of flexor tenolysis in zone 2 following failed flexor tendon repairs. In the control group a standard release was performed. In the treated group, Hyaloglide® was applied into the flexor sheath and around the site of tenolysis. Forty-five patients, 19 controls and 26 treated with Hyaloglide®, were enrolled in 13 centres. All the patients were evaluated at 30, 60, 90 and 180 days after surgery by testing Total Active Motion, Quick-DASH questionnaire and number of working days lost after surgery. Patients in the Hyaloglide® group had a statistically better recovery of finger motion at all time intervals and returned earlier to work and daily activities. The use of Hyaloglide® did not appear to increase the complication rate.

AB - Hyaloglide® is a hyaluronan-based gel based on a novel auto-crosslinked technology designed to reduce postsurgical adhesions. Its efficacy was assessed in a multicentred randomized controlled trial comparing the results of flexor tenolysis in zone 2 following failed flexor tendon repairs. In the control group a standard release was performed. In the treated group, Hyaloglide® was applied into the flexor sheath and around the site of tenolysis. Forty-five patients, 19 controls and 26 treated with Hyaloglide®, were enrolled in 13 centres. All the patients were evaluated at 30, 60, 90 and 180 days after surgery by testing Total Active Motion, Quick-DASH questionnaire and number of working days lost after surgery. Patients in the Hyaloglide® group had a statistically better recovery of finger motion at all time intervals and returned earlier to work and daily activities. The use of Hyaloglide® did not appear to increase the complication rate.

UR - http://www.scopus.com/inward/record.url?scp=76649116868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76649116868&partnerID=8YFLogxK

U2 - 10.1177/1753193409342044

DO - 10.1177/1753193409342044

M3 - Article

VL - 35

SP - 130

EP - 138

JO - Hand

JF - Hand

SN - 1753-1934

IS - 2

ER -